The Great Cannabis Consolidation: What's Really at Stake for Aurora and Curaleaf Hostile takeovers are a common occurrence in industries with shifting regulatory landscapes, expanding export markets, and growing demand.
In cannabis, few companies have been as aggressive in their pursuit of consolidation as Curaleaf, which has made a $4 per share bid for Aurora.
However, the motivations behind this deal go beyond creating a dominant player in the market. Curaleaf's primary interest lies in securing access to Aurora's EU GMP certified cultivation facilities.